BACKGROUND: Adipose tissue is critical for systemic metabolic health. Identifying key factors regulating adipose tissue function is a research priority. The NR4A subfamily of nuclear receptors (NRs) (NR4A1/NUR77, NR4A2/NURR1 and NR4A3/NOR1) has emerged as important proteins in different disease states and in the regulation of metabolic tissues, particularly in liver and muscle. However, the expression of the NR4A members in human adipose tissue has not previously been described, and their target genes are largely unknown. OBJECTIVE: To determine whether the NR4As are differentially expressed in human adipose tissue in obesity, and identify potential NR4A target genes. DESIGN: Prospective analysis of s.c. adipose tissue before and 1 year after fat loss, and during in vitro differentiation of primary human preadipocytes. Case-control comparison of omental (OM) adipose tissue. SUBJECTS: A total of 13 extremely obese patients undergoing biliopancreatic diversion with duodenal switch for fat loss, 12 extremely obese patients undergoing laparoscopic sleeve gastrectomy and 37 lean individuals undergoing hernia repair or laparotomy were included in the study. Measurements were done by quantitative PCR gene expression analysis of the NR4A members and in silico promoter analysis based on microarray data. RESULTS: There was a strong upregulation of the NR4As in extreme obesity and normalization after fat loss. The NR4As were expressed at the highest level in stromal --vascular fraction compared with adipocytes, but were downregulated in both fractions after fat loss. Their expression levels were also significantly higher in OM compared with s.c. adipocytes in obesity. The NR4As were downregulated during differentiation of primary human preadipocytes. Moreover, the NR4As were strongly induced within 30 min of tissue incubation. Finally, promoter analysis revealed potential NR4A target genes involved in stress response, immune response, development and other functions. Our data show altered adipose tissue expression of the NR4As in obesity, suggesting that these stress responsive nuclear receptors may modulate pathogenic potential in humans.
INTRODUCTION
Adipose tissue, skeletal muscle and the liver are important metabolic organs and targets for metabolic therapies. Insulin resistance is a key component of metabolic disorders, and development of insulin resistance and systemic metabolic dysregulation may largely result from an altered function of the adipose tissue, particularly in the intraabdominal compartment. 1, 2 Survival depends on a fundamental evolutionary energy trade-off between immune and metabolic processes, representing a protective homeostatic mechanism. 3 In obesity, however, chronic nutrient excess may lead to an unresolved chronic low-grade inflammation, mediated in part by specific nutrient-responsive kinases that impair insulin signaling and normal metabolic function. 4 It is of great interest to identify transcription factors that mediate this metabolic inflammation in adipose tissue in humans, with the view to find new therapeutic targets.
The nuclear receptor (NR) superfamily comprises 48 highly conserved members divided in several subfamilies. NRs have pivotal roles in development, reproduction, metabolism and homeostasis. 5, 6 In the cell, NRs respond directly to important signaling molecules such as steroid hormones, vitamins A and D, fatty acids and prostaglandins. 7, 8 Moreover, NRs and their cofactors 9, 10 are targeted by various upstream signaling pathways linked to hormonal and neuronal signals. 9, 10 For example, endotoxin exposure and proinflammatory cytokines have been shown to downregulate important metabolic NRs, such as peroxisome proliferator-activated receptor gamma (PPARg). 11, 12 The NR4A subfamily of nuclear receptors comprises NR4A1/ NUR77/NBFIB, NR4A2/NURR1 and NR4A3/NOR1. These NRs have amino-acid residue homology of 97% in the DNA-binding domains, 20 --30% in the N-terminal transactivation domains and 60 --65% in the C-terminal ligand-binding domains. 13 The NR4As are early responders to stimuli such as b-adrenergic signaling, insulin, growth factors, glucose, lipopolysaccharide, lipids, glucagon, inflammation (for example, cytokines) and various forms of cellular stress.
14 They are expressed in high energy-demanding tissues, such as skeletal muscle, liver, heart, kidney, T-cells and brain. 14, 15 These transcription factors have emerged as potentially important regulators in many diseases, 14, 16, 17 being involved in a wide array of functions such as inflammation, cell cycle regulation, apoptosis, steroidogenesis, adipogenesis, angiogenesis and energy metabolism. 17 --19 The NR4A proteins bind to DNA at the NBRE (NGFI-B response element) sequence (5 0 -AAAGGTCA-3 0 ) as monomers and to the palindromic Nur77 response element sequence (5 0 -TGATATTTX6AAATGCCA-3 0 ) as dimers. 20 NUR77 and NURR1 also form heterodimers with retinoic acid receptor. 21 The target genes of the NR4As are largely unknown.
The objective of the present study was to determine whether the expression of the NR4A family members is altered in human adipose tissue in obesity and after fat loss. Adipose tissue samples were collected from two different groups of extremely obese individuals undergoing profound fat loss due to bariatric surgery, as well as from non-obese healthy subjects. On the basis of microarray data, we also sought to identify co-expressed genes in extreme obesity that may be novel NR4A target genes. Our findings suggest that the NR4A members may contribute to the regulation of human adipose tissue function by altered expression in both adipocytes and stromal --vascular cells.
MATERIALS AND METHODS

Ethical statement
The study was approved by the Regional Committee for Medical Research Ethics, and all subjects gave written informed consent.
Subjects and biopsy
We collected blood samples and adipose tissue biopsies from obese subjects during and 1 year after profound fat loss due to bariatric surgery (samples 1 and 3) and from healthy lean subjects (samples 2 and 4) ( Table 1) . The study population consisted of men and women from the age of 42 --61 years. The adipose tissue was obtained by surgical excision both pre-and post-operatively during local anesthesia. For sample 1, whole s.c. adipose tissue biopsies were collected from 13 extremely obese bariatric patients (four men) during and one year after surgery (biliopancreatic diversion with duodenal switch, BPD/DS). Paired omental (OM) and s.c. biopsies were obtained.
For a normal reference, we also collected s.c. fat samples from 13 healthy lean controls undergoing hernia repair (subset of sample 2), and paired whole OM and s.c. adipose tissue from 12 lean subjects undergoing laparotomy surgery (sample 4). Moreover, from 12 extremely obese patients (three men) undergoing laparoscopic sleeve gastrectomy (LSG) (sample 3), we collected OM and s.c. adipose tissue and isolated adipocytes from the other cell types, collectively referred to as the stromal --vascular fraction (SVF), by collagenase treatment. These patients were on a lowenergy diet for 8 weeks before surgery. For comparison, we also isolated s.c. adipocytes and SVF from 12 healthy lean subjects undergoing hernia repair (subset of sample 2).
To assess the effect on NR4A expression during the tissue fractionation procedure (B1 h), we collected whole adipose tissue from three random LSG patients (OM and s.c.) and two lean controls (s.c.), from which one part was immediately frozen and other parts were incubated for 15, 30, 45 and 60 min in physiological buffer.
Adipose tissue homogenization or fractionation
Frozen whole tissue was prepared as previously reported. 22 Fractionation of adipose tissue was achieved by digesting 700 --800 mg of adipose tissue using collagenase and thermolysin (Liberase Blendzyme 3, Roche, Basel, Switzerland). Surface blood was rinsed off in preheated (37 1C) GIBCO Hanks' balanced salt solution (Invitrogen, Paisley, UK), and the tissue was carefully cut into pieces in a mortar using sterile scalpels. The pieces were digested in a 15-ml tube containing 2.6 Wunch units of Liberase Blendzyme 3 (Roche) in 4 ml of preheated Hanks' balanced salt solution. After moderate shaking at 37 1C for 30 min, the digested tissue was transferred to a 10-ml Omnifix syringe (Braun Melsungen, Melsungen, Germany) and carefully filtered through a 25-mm and 200-mm mesh polypropylene filter (Spectrum Laboratories, Rancho Dominguez, CA, USA) inserted into an Easy Pressure syringe filter holder (PALL 4320, Life Sciences, Batavia, IL, USA). To ensure dissolution of the extracellular matrix, 1 ml of Hanks' balanced salt solution/5% bovine serum albumin (A1311, US Biological, Swampscott, MA, USA) was flushed through the filter twice. Adipocytes were allowed to float for a few minutes and were transferred to a 2-ml eppendorf tube, and rinsed with 1 ml Hanks' balanced salt solution/ 5% bovine serum albumin. The remaining SVF was centrifuged at 400 g for 5 min, and cells were lysed in 1 ml Qiazol lysing buffer (Qiagen, Venlo, Netherlands) within 55 ± 5 min after excision. Samples were frozen in nitrogen and stored at À80 1C. 23 with some modifications. Briefly, the tissue was digested by B55 Wunch liter À1 collagenase with thermolysin (Liberase Blendzyme, Roche) in Krebs-Ringer phosphate buffer with 0.1% bovine serum albumin (1:1 tissue and buffer in 50 ml NUNC tubes, Roskilde, Denmark) for 1 --2 h at 37 1C. The digested tissue was filtered through a 210-mm nylon mesh (Sefar Nitex, Heiden, Switzerland) and adipocytes were allowed to float, followed by collection of the SVF and centrifugation for 10 min at 200 g. The adipocytes were washed twice with 15 ml PBS, followed by further collection and centrifugation of stromal --vascular cells after each wash. Red blood cells were lysed in buffer containing 155 mM ammonium chloride, 5.7 mM dipotassium phosphate and 0.1 mM EDTA. Cells were strained through a 70-mm nylon mesh cell strainer (BD Falcon, Franklin Lakes, NJ, USA). Preadipocytes were identified and counted in a Bü rker chamber and cultured in 6-well plates (B500 000 cells per well) in DMEM GlutaMax (GIBCO, Invitrogen, Paisley, UK) with 10% fetal calf serum and 1% penicillin and streptomycin (PEST, GIBCO, Invitrogen). The differentiation medium contained insulin (66 nM l ), which was changed every other day. Cells were treated from day 1. Rosiglitazone (10 mM) was added on day 1, 3 and 5. Cells were harvested in buffer RNeasy Lysis Buffer (Qiagen), vortexed and stored at À80 1C.
RNA extraction, cDNA synthesis and quantitative PCR (qPCR)
We extracted RNA from the adipose tissue samples using the RNeasy Lipid Tissue Midi/Mini Kit (Qiagen). The RNA concentration and quality were measured by NanoDrop (NanoDrop Technologies, Wilmington, DE, USA) ND-1000 spectrophotometer and Agilent 2100 Bioanalyzer. cDNA was synthesized from 100 ng total RNA per sample using the SuperScript VILO cDNA Synthesis Kit (Invitrogen). cDNA was diluted 1:20 with PCR-grade water before qPCR. To make qPCR standard curves (1:10 dilutions), we synthesized cDNA from 2.5 mg total RNA that was extracted from a whole s.c. sample. qPCR was performed using the LightCycler480 rapid thermal cycler system with the LightCycler480 Probes Master kit (Roche). mRNA expression of the NR4A target genes was quantified relative to the mean mRNA expression of TATA-binding protein and low-density lipoprotein receptor-related protein 10 (LRP10), using target-specific primers (Biomers) and Universal ProbeLibrary probes (Roche) (Supplementary Table S1 ). For TATA-binding protein we used the Universal ProbeLibrary Human TBP Gene Assay (Roche). NUR77, IL8 and LRP10 were amplified in duplex with TATA-binding protein, whereas this was not optimal for NURR1 and NOR1. The mRNA concentration values were calculated as the geometric mean with 95% confidence intervals or mean with s.d.. Fold change was calculated based on the mean crossing point of technical duplicates or triplicates, and amplification efficiencies obtained from the standard curves.
Promoter analysis
Genes that were co-expressed with the NR4As in s.c. adipose tissue were identified in our published microarray analysis of the BPD/DS patients in sample 1. 22 The Genomatix (Munich, Germany; http://www.genomatix.de/) Gene2Promoter software was used to identify genes co-expressed with the NR4As whose promoters contain one or more predicted NR4A-binding sites (NBREs). The biological function of these potential target genes was further assessed by the Protein analysis through evolutionary relationships classification system (http://www.pantherdb.org). In addition, in order to identify other transcription factors that also may potentially regulate these genes, the up-and downregulated genes with NBREs were analyzed by the oPOSSUM software (Human Single Site Analysis version 2.0, http:// www.cisreg.ca/cgi-bin/oPOSSUM/opossum, Vancouver, Canada). oPOSSUM searches for conserved transcription factor-binding sites in the promoters of a gene list of interest, and calculates significance values (Z-score and Fisher score) for overrepresentation of transcription factor-binding sites. Transcription factors are defined as overrepresented when there are more binding sites in the co-expressed genes than randomly expected in the genome (binomial statistic). The chosen output parameters (vertebrate matrix) were: top 10% of conserved regions, upstream and downstream sequence length 10 kb, 85% matrix match threshold, Z-score 415 and Fisher score o0.001.
Statistical analysis
Statistical significance was assessed for the qPCR data using nonparametric Wilcoxon-signed ranks test for paired samples and Mann --Whitney U for unpaired samples, and defined as a P-value o0.05. Calculations were performed in SPSS 15.0.1 for Windows, or by the internet-based programs.
RESULTS
Downregulation of the NR4As after fat loss
The BMI of the BPD/DS patients (sample 1) was reduced from 52 to 35 before compared with one year after surgery, and most of the blood values were normalized (Table 1) . qPCR analysis of whole s.c. adipose tissue showed a strong upregulation of the NR4A members in extreme obesity and normalization after fat loss ( Figure 1 ). NUR77 was expressed B23-fold higher before vs after surgery (P ¼ 0.002), NURR1 B5-fold higher (P ¼ 0.002) and NOR1 B7-fold higher (P ¼ 0.002).
Previous studies have implicated a role for the NR4As in adipogenesis and glucose transport in mouse 3T3-L1 cells. 24 --26 However, it is not known to what degree these nuclear receptors are expressed in mature adipocytes in human adipose tissue. We, therefore, collected isolated s.c. adipocytes and SVF before and one year after LSG (sample 3). These patients were on an energyrestricted diet for 8 weeks prior to surgery, during which body weight was significantly reduced by 3 kg (P ¼ 0.013) ( Table 1) . One year after surgery, there was a significant reduction in BMI (45.5 --30.6 kg m À2 ), glucose, triglycerides, insulin and insulin C-peptide. For comparison, we also fractionated s.c. fat from healthy lean subjects (subset of sample 2). We found that the NR4As were predominantly expressed in SVF (Figure 2a ). NUR77 and NURR1 were expressed B6-fold higher and NOR1 B9-nine fold higher in SVF compared with mature adipocytes (all P ¼ 0.003). Though the expression levels were similar in extreme obesity and in lean controls (Figure 2a) , the prospective study of the LSG patients Figure 1 . Upregulation of NR4A in extreme obesity and normalization after fat loss. Paired s.c. adipose tissue samples were collected from 13 extremely obese patients before and 1 year after profound fat loss due to bariatric surgery (BPD/DS) (sample 1). NR4A expression was also measured in s.c. fat from 13 healthy lean individuals undergoing hernia repair (subset of sample 2). mRNA expression of the target genes was measured by qPCR and calculated relative to the geometric mean of reference genes TATAbinding protein (TBP) and low-density lipoprotein receptor-related protein 10 (LRP10). Results are presented as geometric mean with 95% confidence intervals (CI). **Po0.01.
showed a significant 2.1-fold decrease in the expression of NUR77 in adipocytes (P ¼ 0.018), a 2.3-fold decrease of NURR1 (P ¼ 0.028) and a 3.2-fold decrease of NOR1 (P ¼ 0.028). In SVF, there was a significant decrease after surgery in the expression of NURR1 and NOR1 of 3.6-and 3.3-fold, respectively (P ¼ 0.028) (Figure 2b ). Whole tissue from the LSG patients confirmed the reduction in NR4A expression observed after BPD/DS, showing a 5.9-fold decrease in expression of NUR77 (P ¼ 0.066), 5.2-fold decrease of NURR1 (P ¼ 0.01), and 3.6-fold decrease of NOR1 (P ¼ 0.008). There was a larger interindividual variation in the LSG patient group than for the BPD/DS patients, especially for NUR77. The LSG patients also had a relatively lower expression of other stress response genes (for example, IL1B, IL6, IL8 and CCL2) (data not shown).
Increased NR4A expression in OM fat On the basis of the increased disease risk associated with intraabdominal obesity, 27, 28 we next wanted to compare NR4A expression in OM and s.c. fat of the extremely obese BPD/DS patients (sample 1), with reference to the expression in OM and s.c. fat of lean subjects (sample 4). Finally, we wanted to compare NR4A expression in isolated OM and s.c. adipocytes with SVF of the obese LSG patients (sample 3). In whole tissue of extremely obese BPD/DS patients, the expression of the NR4A members was on average increased in OM compared with s.c. fat (1.53-, 1.32-and 1.51-fold for NUR77, NURR1 and NOR1, respectively) ( Figure 3a) . The higher expression was significant only for NOR1 (P ¼ 0.039). There was some interindividual variation in the Figure 3 . Increased NR4A expression in OM adipocytes in obesity. Paired OM and s.c. adipose tissue samples were collected from 13 extremely obese patients before profound fat loss due to bariatric surgery (BPD/DS) (sample 1), and NR4A mRNA expression was compared with 12 lean subjects (sample 4) (a). Also, NR4A expression was compared in paired adipocytes and SVF with OM and s.c. adipose tissue of 12 extremely obese LSG patients (sample 3) (b). The LSG patients were on a low-calorie diet for 8 weeks before surgery. mRNA expression of the target genes was measured by qPCR and calculated relative to the geometric mean of reference genes TBP and LRP10. Results are presented as geometric mean with 95% CI. *Po0.05 (s.c. vs OM); y Po0.05 (obese vs lean). Figure 2 . Downregulation of NR4A in isolated adipocytes and SVF after LSG-induced fat loss. Adipose tissue (s.c.) from 12 extremely obese patients undergoing profound fat loss due to bariatric surgery (LSG) (sample 3) as well as from 12 lean subjects was fractionated into mature adipocytes and SVF (subset of sample 2). The LSG patients were on a low-calorie diet for 8 weeks before surgery. NR4A mRNA levels in isolated adipocytes and SVF were compared with the obese and lean subjects (a), and also with paired isolated samples before compared with 1 year after LSG surgery (b). Whole s.c. adipose tissue from nine of the LSG patients was also analyzed (c). mRNA expression of the target genes was measured by qPCR and calculated relative to the reference gene TBP. Results are presented as geometric mean with 95% CI. *Po0.05; **Po0.01.
depot-specific expression, with some of the patients having a higher expression in s.c. fat (data not shown). In the lean subjects, there were no significant differences in NR4A expression levels between OM and s.c. fat (P ¼ 0.14, P ¼ 0.44 and P ¼ 0.94 for NUR77, NURR1 and NOR1, respectively) (Figure 3a) . Moreover, isolated OM adipocytes from the LSG patients showed a significantly higher expression of the NR4As than s.c. adipocytes (Figure 3b ). NUR77 was expressed 2.1-fold higher, NURR1 2.6-fold higher and NOR1 2.5-fold higher in OM adipocytes (all P ¼ 0.01). There was also a significant 1.46-fold higher expression of NURR1 in OM relative to s.c. SVF (P ¼ 0.028), whereas the 1.42-fold higher expression of NOR1 did not reach statistical significance (P ¼ 0.051).
Acute induction of the NR4As during tissue incubation As the NR4As are immediate-early genes responding to stress, an induction of the NR4As during sample treatment may have influenced the results. We, therefore, measured NR4A expression in whole fat samples that were frozen immediately or incubated in physiological buffer without digestive enzymes for 15, 30, 45 and 60 min. We found a marked increase in expression of the NR4As already after 30 min, and the expression continued to increase at 45 and 60 min (Figure 4 ). The strongest induction was observed for NUR77 (550-fold compared with B18-fold for NURR1 and NOR1, 1 h after biopsy collection). To assess whether proinflammatory mediators were also induced together with the NR4As, we measured the expression of IL8. There was a B700-fold increase in the expression of IL8 by 1 h. The induction of the NR4As and IL8 was similar in biopsies from both lean and obese subjects and in s.c. and OM fat (data not shown).
Decreased NR4A expression during adipocyte differentiation We next wanted to investigate whether NR4A expression was altered during differentiation of primary human preadipocytes. The SVF from adipose tissue of lean and obese women was stimulated in vitro to induce differentiation. As expected, the expression of PPARg2 increased after differentiating stimuli ( Figure 5 ). At 2 days after treatment, the SVF of a lean woman showed a 1.5-fold decrease in NUR77 mRNA, a 4.4-fold decrease in NURR1 mRNA and a 3.1-fold decrease in NOR1 mRNA, followed by a suppressed expression level throughout the differentiation (Figure 5a ). The effect of the differentiation stimuli was similar but more pronounced in SVF of an obese woman (13-, 10.5-and 7.5-fold decrease from day 0 to day 2 for NUR77, NURR1 and NOR1, respectively) (Figure 5b) . There was also a rebound in the expression of NOR1 by day 6.
In silico promoter analysis of potential NR4A target genes Identifying new NR4A targets may provide an insight into their biological functions. We previously performed global gene expression analysis of adipose tissue before vs 1 year after BPD/ DS surgery (sample 1), showing that the NR4As were among 469 downregulated genes after the profound fat loss. 22 A total of 152 genes were upregulated and hence, regulated in the opposite direction to the NR4As. To analyze genes and biological processes that may be regulated by the NR4As, we searched for NBREs in these co-expressed genes. The analysis revealed 41 NBREs in 241 of the downregulated, and 89 of the upregulated genes. A majority of the downregulated genes with NBREs mapped to Figure 4 . Rapid and marked induction of NR4As during tissue incubation. Adipose tissue samples were collected from three extremely obese LSG patients (subset of sample 3) and two lean subjects (subset of sample 2). One part of each biopsy was frozen immediately and other parts were frozen at 15, 30, 45 and 60 min. For the extremely obese subjects, both s.c. and OM fat was analyzed. The mRNA expression was measured by qPCR, calculated relative to the geometric mean of TBP and LRP10 and presented as geometric mean with 95% CI (n ¼ 8). ) and T3 (1 nM l À1 ), which was changed every other day. In addition, rosiglitazone (10 mM) was added on day 1, 3 and 5. Cells were harvested in buffer RLT, vortexed, and stored at --80 1C. NR4A expression was measured by qPCR and calculated relative to the geometric mean of reference genes TBP and LRP10. The results are presented as mean±s.d. of biological triplicates each from triplicate wells. the category metabolic process, particularly related to signal transduction ( Figure 6, Supplementary Table S2 ). Other overrepresented categories included stress response, immune system processes and developmental processes. Moreover, we also systematically interrrogated what other transcription factors may have regulated the potential NR4A target genes, and found that NBRE-containing genes had the most overrepresented presence of binding elements for CREB, members of the Rel/NFKB family (REL, RELA) and members of the E-twenty six family (SPIB) (Supplementary Table S3 ).
DISCUSSION
In the present study, we have demonstrated that the members of the nuclear receptor 4A family (NR4A) are differentially expressed in the adipose tissue of extremely obese individuals. We observed a downregulation of NR4A expression after profound fat loss in whole tissue, in isolated adipocytes and in the SVF, and a higher expression of NR4A in OM compared with s.c. fat. These effects on NR4A gene expression are unlikely to have resulted from the bariatric surgery per se (that is, anatomical changes in the gastrointestinal tract), as the NR4A expression was elevated before surgery compared with lean controls. We also found a decreased expression of the NR4As during human preadipocyte differentiation. The findings support a role for these transcription factors in the regulation of adipose tissue function in humans.
We observed that the NR4As were overexpressed in extreme obesity together with myriad factors related to stress response and inflammation, which were normalized or near-normalized after fat loss in our global gene expression study. 22 During the 1-h biopsy incubation, we found a similar rapid induction of IL8, indicating that the NR4As are part of a co-expressed network of proinflammatory factors. NUR77 and NURR1 were previously found to be induced within 30 min in T cells, 29 which was the time necessary to induce NR4A expression upon incubation in the present study of adipose tissue. In skeletal muscle, b-adrenergic stimulation induced NUR77 within 30 --60 min. 30 Our data indicate that the NR4As operate early in a proinflammatory cascade in adipose tissue, and may thus have a role in mediating a chronic low-grade inflammation. This is further corroborated by our promoter analysis of genes coregulated with the NR4As in human adipose tissue, showing potential NR4A-binding elements in genes such as EGR2, EGR3, DDX21, DDX47, DDX5, DUSP1, DUSP5, FOSL1, FOXC1, HIF1A, NFKBIZ, TSC22D1, TSC22D2 and VEGFA. It has previously been reported that the NR4As induce several inflammatory mediators. 17, 19, 31 Infiltration/activation of macrophages in adipose tissue may be a critical event in obesity-related chronic low-grade inflammation. 4, 32 Interestingly, it was shown that overexpression of Nur77 in murine macrophages induced the inhibitor of k kinase, 31 a key nutrient responsive inflammatory mediator upstream in the NF-kB pathway, and which may directly impair insulin signaling. 4 Moreover, NUR77 has been Figure 6 . Functional categorization of potential NR4A-target genes in adipose tissue. Protein analysis through evolutionary relationships classification system (PANTHER) was used to search for overrepresented biological process categories among NBRE-containing genes that were co-expressed with the NR4As in s.c. fat of 16 extremely obese BPD/DS patients. The color intensity displays the binomial statistical significance (Àlog P-value) of over-and underrepresented PANTHER functional categories. A P-valueo0.01 was used as the inclusion criterion for categories. Numbers presented in the table indicate the percentage of genes within a gene set that map to the given category, for example, 22% of the 241 genes with increased expression in extreme obesity map to 'Response to stimulus' . The first column states the overall distribution of a term among all human NCBI genes (19 911), for example, 9% of the genes are expected to map to 'Response to stimulus' , hence this category is significantly overrepresented. Ref, reference (based on all human NCBI genes). Up, upregulated genes during high NR4A expression; Down, downregulated genes during high NR4A expression.
shown to sustain hypoxia inducible factor 1 protein levels, a key mediator of cellular responses to hypoxia, 33 which may underlie adipose tissue inflammation in obesity. 34 --36 Thus, our data support a role for the NR4As in modulating inflammatory responses to nutrients and other factors in human adipocytes, macrophages and potentially other cell types. Possibly, the increased NR4A expression in OM compared with s.c. adipocytes in obesity may contribute to a more pronounced OM inflammatory response.
Our data furthermore suggest that the NR4As may be dynamically regulated depending on the nutritional state. The BPD/DS patients showed normalized levels of the NR4As, despite a BMI in the obese range after profound fat loss (32.4 kg m À2 ) compared with lean controls (22.8 kg m À2 ). The expression of the NR4As and other stress response genes may be reduced because of a catabolic state, independent of the BMI level. The less increased NR4A expression in the extremely obese LSG bariatric patients, who consumed an energyrestricted diet 8 weeks prior to surgery, suggests that NR4A expression in adipose tissue may decrease during a reduced food intake and moderate fat loss. It is also interesting to note that energy restriction of rats led to an increased NR4A expression in liver and muscle, 37 and that refeeding after fasting decreased expression of Nur77 and Nor-1 whereas increased Nurr1 expression in white adipose tissue of mice. 26 Further studies should investigate NR4A expression in human adipose tissue during dietary interventions.
The differential expression of the NR4As in human adipose tissue could potentially affect key metabolic processes such as lipolysis, lipogenesis, glucose transport and energy expenditure. NUR77 knockdown was found to suppress lipolysis in skeletal muscle cells.
14,30 Also, NUR77 has been shown to suppress Sterol regulatory element binding protein 1c activity in hepatocytes, 38 a lipogenic transcription factor with reduced expression in adipose tissue in obesity. 39 However, inhibition of the NR4A members did not affect lipid accumulation in terminally differentiated 3T3-L1 mouse adipocytes. 25 Furthermore, the NR4As have been proposed as key regulators of hepatic glucose metabolism. 40 In 3T3-L1 cells, NUR77 and NOR1 were found to be induced by insulin, and NOR1 overexpression enhanced GLUT4 translocation to the plasma membrane, suggesting a stimulatory effect on insulin-mediated glucose transport. 24 Finally, b-adrenergic stimulation has been demonstrated to promote direct NR4A-mediated transactivation of the UCP1 promoter, 14, 17, 41 which is involved in the dissipation of energy as heat in brown adipocytes. These diverse effects on metabolic processes, together with the obesity-dependent expression that we have observed in both adipocytes and SVF from humans, suggest that the NR4As may be important metabolic regulators in human adipose tissue.
We found a decrease in NR4A expression during differentiation of human preadipocytes. Previous studies of 3T3-L1 cells have suggested that the NR4A members are induced in the early stages of adipocyte differentiation (within 1 --2 h). 25, 42 However, functional studies in mice suggest that they inhibit adipocyte differentiation. 26 The decrease we observed in NR4A expression during human preadipocyte differentiation supports that these nuclear receptors are regulated opposite to adipogenic genes in humans. The NR4As are induced by the mitogen-activated protein kinase pathway via Ser133 phosphorylation of the transcription factor CREB, 43 and this pathway inhibits adipogenesis by suppressing PPARg2 expression in response to mechanical stretching of adipocytes. 44 As both NR4As and PPARg can heterodimerize with retinoic acid receptor, the NR4As could interfere with PPARg binding to promoters of target genes. By transfecting COS-1 cells with a plasmid construct containing a PPARg response element fused to the luciferase gene, we however found no inhibitory effect of NR4A overexpression on PPARg2-mediated transactivation (data not shown). Moreover, there are at least three binding elements for the NR4As (NBREs) in the promoter of PPARg, suggesting that NR4A may suppress PPARg expression during chronic inflammation.
In conclusion, several studies have implicated the NR4As as potential key factors in inflammation and metabolism. We have shown that the NR4A family members are upregulated in human obesity, particularly in OM fat. The altered expression in isolated adipocytes supports a role for these nuclear receptors in adipocyte stress responses and metabolic processes in humans.
